Dashboard
Manage Tickers

NSPRInspireMD, Inc.

Nasdaq inspiremd.com


$ 2.90 $ -0.01 (-0.34 %)    

Monday, 05-Aug-2024 15:31:13 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 437.97 $ -13.38 (-2.98 %)
DIA $ 386.91 $ -10.32 (-2.6 %)
SPY $ 518.58 $ -15.52 (-2.91 %)
TLT $ 98.76 $ 0.52 (0.53 %)
GLD $ 222.59 $ -2.86 (-1.27 %)
$ 2.96
$ 2.89 x 100
-- x --
-- - --
$ 1.81 - $ 3.85
32,761
na
106.2M
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-05-2024 12-31-2023 10-K
4 11-06-2023 09-30-2023 10-Q
5 08-07-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-07-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-07-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-08-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-05-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-10-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-05-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 08-06-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 02-13-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 02-16-2017 12-31-2016 10-K
32 11-14-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-28-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-05-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-12-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inspiremd-presents-one-year-follow-up-results-from-c-guardians-us-ide-trial-of-cguard-at-linc-2024-on-may-28-at-853-am-edt
InspireMD Presents One-Year Follow-Up Resu...
05/28/2024 12:56:08

inspiremd-q1-2024-gaap-eps-021-misses-015-estimate-sales-1511b-beat-1384m-estimate
InspireMD Q1 2024 GAAP EPS $(0.21) Misses ...
05/14/2024 10:27:28

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) b...

inspiremd-announces-abstract-of-one-year-follow-up-results-from-c-guardians-us-investigational-device-exemption-clinical-trial-accepted-for-presentation-at-linc-2024
InspireMD Announces Abstract Of One-year F...
03/26/2024 11:13:59

inspiremd-q4-eps-016-beats-020-estimate-sales-176m-beat-163m-estimate
InspireMD Q4 EPS $(0.16) Beats $(0.20) Est...
03/06/2024 12:01:21

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.20) by ...

earnings-scheduled-for-march-6-2024
Earnings Scheduled For March 6, 2024
03/06/2024 10:00:02

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

preview-inspiremds-earnings
Preview: InspireMD's Earnings
03/05/2024 19:02:55

inspiremd-appoints-principal-investigators-for-its-upcoming-c-guardians-ii-clinical-trial-of-switchguard-neuroprotection-system
InspireMD Appoints Principal Investigators...
02/12/2024 12:05:22

inspiremd-receives-ce-mark-recertification-under-eus-new-medical-device-regulation-mdr-regulatory-framework
InspireMD Receives CE Mark Recertification...
01/31/2024 12:05:59

inspiremd-reveals-issuance-of-key-us-patent-covering-its-switchguard-neuroprotection-system
InspireMD Reveals Issuance Of Key U.S. Pat...
12/20/2023 12:02:13

inspiremd-enters-into-an-agreement-with-jacobs-institute-at-the-state-university-of-new-york-for-an-early-feasibility-study-of-cguard-eps-carotid-stent-in-conjunction-with-thrombectomy-in-patients-with-acute-ischemic-stroke-and-tandem-lesions
InspireMD Enters Into An Agreement With Ja...
11/27/2023 12:08:37

earnings-scheduled-for-november-6-2023
Earnings Scheduled For November 6, 2023
11/06/2023 13:24:53

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on ...

inspiremd-sold-2734-cguard-eps-stent-systems-in-q3-compared-to-2624-a-year-ago
InspireMD Sold 2,734 CGuard EPS Stent Syst...
11/06/2023 12:06:46

inspiremd-q3-eps-015-inline-sales-156m-beat-150m-estimate
InspireMD Q3 EPS $(0.15), Inline, Sales $1...
11/06/2023 12:04:36

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 74.1...

inspiremd-earnings-preview
InspireMD Earnings Preview
11/03/2023 20:01:50

piper-sandler-maintains-overweight-on-inspiremd-raises-price-target-to-45
Piper Sandler Maintains Overweight on Insp...
11/02/2023 19:58:27

Piper Sandler analyst Adam Maeder maintains InspireMD (NASDAQ:NSPR) with a Overweight and raises the price target from $3.5 ...

inspiremd-presents-30-day-follow-up-results-from-the-c-guardians-us-investigational-device-exemption-clinical-trial-at-viva23
InspireMD Presents 30-Day Follow-Up Result...
11/01/2023 18:26:38

InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, tod...

inspiremd-announced-its-support-for-centers-for-medicare--medicaid-services-final-national-coverage-determination-which-expands-coverage-of-carotid-artery-stenting-and-transcarotid-artery-revascularization-to-include-asymptomatic--standard-risk-patients
InspireMD Announced Its Support For Center...
10/12/2023 11:29:36

inspiremd-announces-abstract-of-30-day-results-from-the-c-guardians-us-investigational-device-exemption-clinical-trial-accepted-for-presentation-at-viva23
InspireMD Announces Abstract Of 30-Day Res...
08/31/2023 12:07:28

InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, tod...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
08/23/2023 21:32:28

inspiremd-q2-eps-024-beats-030-estimate-sales-165m-beat-155m-estimate
InspireMD Q2 EPS $(0.24) Beats $(0.30) Est...
08/08/2023 11:07:45

InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION